2Brading AF.A myogenic basis for the overactive bladder.Urology,1997,50:57-73.
3Drake MJ,Harvey IJ,Gillespie JI.Autonomous activity in the isolated guinea pig bladder.Exp Physiol,2003,88:19-30.
4Davidson RA,McCloskey KD.Morphology and localization of interstitial cells in the guinea pig bladder:structural relationships with smooth muscle and neurons.J Urol,2005,173:1385-1390.
5Lagou M,De Vente J,Kirkwood TB,et al.Location of interstitial cells and neurotransmittera in the mouse bladder.BIU Int,2006,97;1332-1337.
6Yost MJ,Simpson D,Wrona K,et al.Design and construction of a uniaxial celt stretcher.Am J Physiol Heart Circ Physiol,2000,279:3124-3130.
7Johnston L,Carson C,Lyons AD,et al.Cholinergic-induced Ca^(2+) signaling in interstitial cells of Cajal from the guinea pig bladder.Am J Physiol Renal Physiol,2008,294:645-655.
8McCloskey KD,Gurney AM.Kit positive cells in the guinea pig bladder.J Urol,2002,168:832-836.
9Hashitani H.Interaction between interstitial cells and smooth muscles in the lower urinary tract and penis.J Physiol,2006,576:707-714.
5Leone Roberti Maggiore U, Salvatore S, Alessandri F, et al. Pharmacokinetics and toxicity of antimuscafinic drugs for overactive bladder treatment in females[J]. Expert Opin Drug Metab Toxicol, 2012, 8(11): 1387-1408.
6Fall M, Erlaneson BE, Nilson AE, et al. Long-term intravaginal electrical stimulation in urge and Stress incontinence[J]. Scand J Urol Nephol Suppl, 1977(44): 55-63.
7Digesu GA, Khullar V, Cardozo L, et al. Overactive bladder symptoms: do we need urodynamics? [J]. Nenrourol Urodyn, 2003, 22(2): 105-108.
8Chapple CR, Fianu-Jonsson A, Indig M, et al. Treatment outcomes in the STAR study : a subanalysis of solifenacin 5 mg and tolterodine ER 4 mg[ J ]. Eur Urol, 2007, 52 : 1195-1203.
9Chapple CR, Rechberger T, A1-Shukri S, et double-blind placebo- and al. Randomized, trial of the once- daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder[J]. BJU Int, 2004, 93:303-310.
10Chapple CR, Araeio P, Bosch JL, et al. Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo- and toherodine-controlled phase 2 dose-finding study[ J]. BJU Int, 2004, 93:71-77.
